CLARITY PV has been introduced to global Pharmacovigilance audience

This summer, Chemotargets was presenting CLARITYpv at several international audience conferences:

30th June – 2nd July – Japan Society of Toxicology, Tokushima (Japan) https://www.jsot2022.jp/
Conference link
Conference link

Previous PostChemotargets is a partner in REMEDi4ALL, an ambitious EU-funded research initiative, to drive forward the repurposing of medicines in Europe
Next PostAcellera and Chemotargets to Collaborate -Enhancing AI and Physics Based Drug Discovery